Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial120

File Visits

Downloads
36218-371.pdf46

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial44

Number of downloads in the range

Downloads
36218-371.pdf17

Views

Views
October 20251
November 202510
December 20253
January 202622
February 20260
March 20268
April 20260
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • October 2025
    1
  • November 2025
    3
  • December 2025
    4
  • January 2026
    6
  • February 2026
    0
  • March 2026
    1
  • April 2026
    2
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States25
Brazil4
Algeria2
Peru2
Colombia2
Argentina1
Canada1
Finland1
United Kingdom1
Mexico1
 

Top countries by downloads

Downloads
United States11
 

Top cities views

Views
San Jose14
Santiago de Cali2
Ashburn1
Barquisimeto1
Batna City1
Belo Horizonte1
Caucete1
Cleveland1
Constantine1
Dakar1
 

Top cities by downloads

Downloads